This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PBS's Nova ScienceNow Features Harvard Bioscience Bioreactors For Lung And Airway Regeneration

HOLLISTON, Mass., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, is pleased to announce that its LB2 Lung Regeneration Bioreactor was featured on PBS's Nova ScienceNow television program on January 27, 2011. The lung research and transplantation work was conducted by Dr. Harald Ott at Massachusetts General Hospital.

Harvard Bioscience's bioreactor is featured in a segment of the program titled "Replacing Body Parts," focusing on the ability of new technology to grow human organs, including hearts, lungs and airways for transplantation. The segment includes footage of Claudia Castillo, the recipient of an airway regenerated from her own cells in a different bioreactor, the InBreath Hollow Organ Regeneration Bioreactor, and transplanted by Dr. Paolo Macchiarini. The InBreath technology is exclusively licensed to Harvard Bioscience. Dr. Macchiarini notes that Ms. Castillo is not only leading a normal, productive life but, because the airway was grown from her own cells, has never taken immune suppression drugs. In a normal human organ transplant the recipient needs to take immune suppression drugs for life which is both costly and makes the patient vulnerable to infection.

The host of the program, Dr. Neil deGrasse Tyson, notes that approximately 20 Americans die every day while waiting for an organ transplant and that this technology creates the potential for an unlimited supply of organs for transplantation and the elimination of waiting lists for transplant recipients. Dr. Joseph Vacanti, also of Massachusetts General Hospital, notes that the US waiting list for organ transplants is over 100,000 people. Dr. Doris Taylor of the University of Minnesota, who created the world's first regenerated heart, notes that she believes the large-scale implementation of this technology in hospitals is not decades but only years away.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs